Holen Sie sich die Stockscreener-App
3.03
1.94%
-0.06
Handel nachbörslich:
3.06
0.03
+0.99%
Schlusskurs vom Vortag:
$3.09
Offen:
$3.14
24-Stunden-Volumen:
217.04K
Relative Volume:
0.51
Marktkapitalisierung:
$9.22M
Einnahmen:
-
Nettoeinkommen (Verlust:
$2.81M
KGV:
-0.2112
EPS:
-14.3497
Netto-Cashflow:
$7.14M
1W Leistung:
+1.00%
1M Leistung:
-5.31%
6M Leistung:
-21.71%
1J Leistung:
-34.13%
1-Tages-Spanne:
$2.96
$3.15
1-Wochen-Bereich:
$2.96
$3.29
52-Wochen-Spanne:
$2.51
$4.80
Kiora Pharmaceuticals Inc Stock (KPRX) Company Profile
Firmenname
Kiora Pharmaceuticals Inc
Sektor
Branche
Telefon
781-788-8869
Adresse
332 ENCINITAS BOULEVARD, ENCINITAS
Vergleichen Sie KPRX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
KPRX
Kiora Pharmaceuticals Inc
|
3.03 | 9.13M | 0 | 2.81M | 7.14M | -14.35 |
|
VRTX
Vertex Pharmaceuticals Inc
|
470.13 | 119.21B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.93 | 59.16B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
325.28 | 40.57B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
571.23 | 34.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
295.59 | 29.19B | 3.81B | -644.79M | -669.77M | -6.24 |
Kiora Pharmaceuticals Inc Aktie (KPRX) Neueste Nachrichten
KPRX Receives Positive Outlook Following New U.S. Patent | KPRX Stock News - GuruFocus
Kiora Pharmaceuticals stock rises after receiving patent for KIO-104 By Investing.com - Investing.com Nigeria
Kiora Pharmaceuticals receives patent for ocular disease treatment - Investing.com
Kiora Secures Crucial Patent for Eye Disease Drug KIO-104 as Phase 2 Trial Advances - Stock Titan
What drives Kiora Pharmaceuticals Inc. stock priceDouble or triple returns - jammulinksnews.com
What analysts say about Kiora Pharmaceuticals Inc. stockFree Expert Stock Watchlist - Autocar Professional
Is Kiora Pharmaceuticals Inc. a good long term investmentExceptional earning trajectories - jammulinksnews.com
Kiora Pharmaceuticals Inc. Stock Analysis and ForecastRecord-breaking capital gains - jammulinksnews.com
Why Kiora Pharmaceuticals Inc. stock attracts strong analyst attentionFree Top-Rated Stock Analysis - Newser
Kiora Pharmaceuticals (KPRX) Upgraded to Strong Buy: Here's What You Should Know - MSN
Retinitis Pigmentosa Treatment Market Driven by Gene Therapy - openPR.com
How Kiora Pharmaceuticals Inc. stock performs during market volatilityFree Smart Money Stock Analysis - Newser
What makes Kiora Pharmaceuticals Inc. stock price move sharplyPredictable Return Stock Picks - Newser
Kiora Pharmaceuticals (NASDAQ:KPRX) Trading 1.8% Higher – Here’s Why - Defense World
Kiora Pharmaceuticals (NASDAQ:KPRX) Trading Down 0.3% – Here’s Why - Defense World
Kiora Pharmaceuticals and Senju Pharmaceutical partner on KIO-301 for retinal disease treatment in Asia - Ophthalmology Times
kiora pharmaceuticals reports results of annual shareholder meeting By Investing.com - Investing.com South Africa
kiora pharmaceuticals reports results of annual shareholder meeting - Investing.com
Kiora Pharmaceuticals Holds Annual Meeting, Elects Directors - TipRanks
Oil Prices Climb While US Equity Futures Stutter - Finimize
MAG 8 Momentum: NIVF, TRAW, KPRX, PNPN.V Lead $3 Undercard SurgeMore Stocks Inside! - openPR.com
Pre-market Movers: STSS, SGMT, NIVF, OGEN... - RTTNews
MAG 8 Momentum: NIVF, TRAW, KPRX, PNPN.V Lead $3 Undercard Surge – More Stocks Inside! - FinancialContent
Markets | American Financial Group, Inc. - FinancialContent
Kiora Pharmaceuticals inks potential $110 million deal with Senju By Investing.com - Investing.com South Africa
ReShape Lifesciences And Kiora Pharma Impress Investors, Dollar General Uplifts Outlook - Finimize
Sector Update: Health Care - marketscreener.com
Kiora Pharmaceuticals Stock Skyrockets Over 20% in Dynamic Trading Session - Daily Chhattisgarh News
Traws Pharma Inc. Stock Skyrockets Over 40%, Then Pares Gains in Volatile Trading - Daily Chhattisgarh News
Pre-market Movers: NIVF, TRAW, KKR, AGEN... - RTTNews
Kiora PharmaceuticalsEnters Exclusive Option Agreement With SenjuSEC Filing - marketscreener.com
Kiora Pharmaceuticals inks potential $110 million deal with Senju - Investing.com
Kiora Pharmaceuticals and Senju Pharmaceutical Partner on KIO-30 - GuruFocus
Finanzdaten der Kiora Pharmaceuticals Inc-Aktie (KPRX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):